These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28774844)

  • 1. Assessing Old and New Diagnostic Tests for Gastroesophageal Reflux Disease.
    Vaezi MF; Sifrim D
    Gastroenterology; 2018 Jan; 154(2):289-301. PubMed ID: 28774844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in diagnostic testing for gastroesophageal reflux disease.
    Naik RD; Vaezi MF
    Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):531-537. PubMed ID: 28317452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of dilated intercellular space and histopathologic scores in gastroesophageal reflux disease.
    Cui R; Zhang H; Zhou L; Lu J; Xue Y; Wang Y; Yan X; Lin L; Lin S
    Dis Esophagus; 2015; 28(6):530-7. PubMed ID: 25130660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory Gastroesophageal Reflux Disease and Functional Heartburn.
    Spechler SJ
    Gastrointest Endosc Clin N Am; 2020 Apr; 30(2):343-359. PubMed ID: 32146950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory Heartburn: A Challenging Problem in Clinical Practice.
    Domingues G; Moraes-Filho JPP; Fass R
    Dig Dis Sci; 2018 Mar; 63(3):577-582. PubMed ID: 29352757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
    Pace F; Pace M
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent gastro-oesophageal reflux symptoms despite proton pump inhibitor therapy.
    Ang D; How CH; Ang TL
    Singapore Med J; 2016 Oct; 57(10):546-551. PubMed ID: 27779277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heartburn, gastroesophageal reflux (GER), and gastroesophageal reflux disease (GERD).
    J Pract Nurs; 2008; 58(3):21-3. PubMed ID: 19180847
    [No Abstract]   [Full Text] [Related]  

  • 10. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.
    Kandulski A; Weigt J; Caro C; Jechorek D; Wex T; Malfertheiner P
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1075-81. PubMed ID: 25496815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic work-up of GERD.
    Vela MF
    Gastrointest Endosc Clin N Am; 2014 Oct; 24(4):655-66. PubMed ID: 25216910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Noncardiac chest pain and gastroesophageal reflux disease].
    Dimache M; Turcan E; Nătase M
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):342-8. PubMed ID: 20700964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett's esophagus.
    Baldaque-Silva F; Vieth M; Debel M; Håkanson B; Thorell A; Lunet N; Song H; Mascarenhas-Saraiva M; Pereira G; Lundell L; Marschall HU
    World J Gastroenterol; 2017 May; 23(17):3174-3183. PubMed ID: 28533674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with refractory reflux symptoms often do not have GERD.
    Herregods TV; Troelstra M; Weijenborg PW; Bredenoord AJ; Smout AJ
    Neurogastroenterol Motil; 2015 Sep; 27(9):1267-73. PubMed ID: 26088946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives.
    Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Savarino V; Savarino E
    Dig Dis Sci; 2017 Aug; 62(8):1881-1889. PubMed ID: 28550489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of salivary pepsin for gastroesophageal reflux disease.
    Yadlapati R; Kaizer A; Greytak M; Ezekewe E; Simon V; Wani S
    Dis Esophagus; 2021 Apr; 34(4):. PubMed ID: 33180095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proton pump inhibitor (PPI) test in GERD: does it still have a role?
    Gasiorowska A; Fass R
    J Clin Gastroenterol; 2008 Sep; 42(8):867-74. PubMed ID: 18645525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease.
    Saritas Yuksel E; Hong SK; Strugala V; Slaughter JC; Goutte M; Garrett CG; Dettmar PW; Vaezi MF
    Laryngoscope; 2012 Jun; 122(6):1312-6. PubMed ID: 22447277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of clinical severity and investigation of uncomplicated gastroesophageal reflux disease and noncardiac angina-like chest pain.
    Lemire S
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():37B-40B. PubMed ID: 9347176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.